NCT05275075Terminated
Identify microRNAs in Cachexia in Pancreatic Carcinoma
Pilot Trial to Identify microRNAs in Cachexia in Patients With Pancreatic Carcinoma
Source: ClinicalTrials.gov · Last updated 1 Jun 2026
Reason given: Translational scientist left university
Brief summary (registry, in English)
The purpose of this study is to determine the proportion of pancreatic patients who experience weight loss and cachexia, and to identify any differences in the genes between patient groups.
- Status (registry)
- Terminated
- Study type
- Observational
- Enrollment
- 40 (actual)
- First submitted
- 2 Mar 2022
- Start date
- 7 Dec 2022
- Primary completion date
- 3 Apr 2026
- Lead sponsor
- University of Oklahoma
- Diseases
- Pancreatic cancer
- NCT number
- NCT05275075
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with pancreatic adenocarcinoma who do not meet the criteria for surgical resection.
Other illness
- Patient has cancer diagnosis other than primary pancreatic adenocarcinoma.
Who the study is looking for
- Male or female patient, who is ≥ 18 years old at the time of informed consent.
- Patients with operable pancreatic tumors diagnosed in the last 12 months prior to consent with clinical discretion or pathology confirmed as adenocarcinoma.
- Patient has stage I or higher disease who is considered a candidate for surgical resection of pancreatic cancer, with or without neoadjuvant chemotherapy.
- Ability to provide written informed consent and HIPAA authorization.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Stephenson Cancer Center | Oklahoma City | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.